Latest news
SK Biopharmaceuticals' Attributable Net Income Surges 158% in Q2; Shares Rise 5% - MoomooMoomoo · Wed, 05 Aug 2026 05:11:10 GMTSK Biopharmaceuticals Posts Record Q2 Operating Profit of ₩97.1 Billion on Surging US Xcopri Sales - finance.biggo.comfinance.biggo.com · Wed, 05 Aug 2026 02:27:00 GMTSK Biopharmaceuticals Posts Record Earnings on 45.6% Jump in Cenobamate U.S. Sales - Seoul Economic DailySeoul Economic Daily · Wed, 05 Aug 2026 01:37:51 GMTSK Biopharm expands Latin America push with Brazil launch - The Korea HeraldThe Korea Herald · Wed, 29 Jul 2026 05:19:48 GMT